Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Bernstein Reiterates Market Perform Rating on Moderna (MRNA)
-
Tyson (TSN) PT Raised to $60 at Bernstein SocGen Group
-
Amadeus IT Group SA (AMS:SM) (AMADY) PT Raised to EUR87 at Bernstein
-
Sea Ltd earnings preview Q3: strong print expected on robust gaming, ecommerce
-
AMD analyst day: Bernstein says expectations are high
-
This is the best U.S. defense stock to own at the moment: Bernstein
-
Minimus Recognized as a CRN® 2025 Stellar Startup!
-
UL Solutions to Attend Upcoming Investor Conferences
-
Wealthspire to Acquire RoundAngle Advisors
-
Lyft (LYFT) PT Raised to $23 at Bernstein SocGen Group
-
Bernstein: 'Diageo PLC. (DGE:LN) (DEO) Lands a Serious Heavy-Hitter as CEO'
-
Bernstein on Expedia (EXPE): 'An Inflection Point?'
-
Bernstein Sees 'Room For More Upside' at Hyatt Hotels (H)
-
Bernstein on L3Harris Technologies (LHX): 'Our Top Choice in US Defense'
-
Bernstein Shares Key Takeaways From Meeting With Adobe (ADBE) Management
-
SanDisk (SNDK) Stock PT Raised to $300 from $120 at Bernstein
-
Block Inc. (XYZ) PT Lowered to $90 at Bernstein
-
Wendy's (WEN) PT Lowered to $10 at Bernstein
-
DraftKings Inc. (DKNG) PT Lowered to $41 at Bernstein
-
Form 497 BERNSTEIN SANFORD C FUND
-
Bernstein SocGen Group Upgrades Sungrow Power Supply Company (300274:CH) to Outperform
-
Bernstein SocGen Group Upgrades Prada SpA (1913:HK) (PRDSY) to Outperform
-
U.S. Retailing Broadlines & Hardlines: Q3 earnings preview
-
Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497 BERNSTEIN SANFORD C FUND
-
Summit Health Physicians Earn National Recognition as 2025 Jersey Choice “Top Doctors”
-
James Hardie Announces Participation At Upcoming Investor Conferences and Timing of Second Quarter FY26 Earnings Release & Conference Call
-
Bernstein on US Foods (USFD): 'Leaning In on Performance'
-
Bernstein Reiterates Outperform Rating on Airbnb Inc. (ABNB)
-
Bernstein SocGen Group Reiterates Outperform Rating on TripAdvisor (TRIP)
-
Home Depot (HD) PT Raised to $406 at Bernstein SocGen Group
-
Bernstein: 'We Continue to Prefer Lowe's (LOW) Over HD'; PT Raised to $282
-
Bernstein on Tapestry Inc. (TPR): 'We Would Be Buying Today's Dip'; PT Raised
-
Diageo PLC. (DGE:LN) (DEO) PT Lowered at Bernstein Following Guidance Cut
-
Huntington Ingalls (HII) PT Raised to $362 at Bernstein
-
Cummins (CMI) PT Raised at Bernstein on 'Strength of Power Gen'
-
Bernstein explains why this big pharma stock 'should continue to work'
-
Form 485BPOS BERNSTEIN SANFORD C FUND
-
Wendy's faces profit squeeze with earnings projected to drop 18% in fiscal 2025
-
Bernstein SocGen Group Downgrades DHL Group (DHL:GR) to Market Perform
-
This stock is 'an underappreciated growth story'
-
Celldex reports positive barzolvolimab results in chronic urticaria study
-
Celldex Presents Results from Barzolvolimab Phase 2 Study in Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Demonstrating Sustained Efficacy and Favorable Safety Profile over 20 Week Placeb
-
Bernstein: 'Performance Food Group (PFGC) Defying Macro Gravity'
-
Bernstein on Trimble Navigation (TRMB): '3Q Execution Provides a Good Exit Rate'
-
Maze Therapeutics presents drug data at kidney conference
-
Bernstein Reiterates Market Perform Rating on Pfizer (PFE)
-
Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week

